FindTrial
Sign In

Effect of domperidone on breast milk production in mothers of sick neonates: a randomized, double-blind, placebo-controlled trial

Effect of domperidone on breast milk production in mothers of sick neonates: a randomized, double-blind, placebo-controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20200910008
Enrollment
Unknown
Registered
2020-09-10
Start date
2012-07-02
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lactation failure in mothers Lactation failure&#44

Interventions

Domperidone (10 mg) 2 tablets 3 times a day,Placebo tablet with similar appearance and odor 2 tablets 3 times a day
Experimental Drug,Placebo Comparator Drug
Domperidone,Placebo tablet

Sponsors

Queen Sirikit National Institute of Child Health
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Mothers of babies admitted to the neonatal unit of Queen Sirikit National Institute of Child Health and experiencing lactation failure (LF)

Exclusion criteria

Exclusion criteria: Women who had any contraindications for breastfeeding, mothers who had already received domperidone any time after the delivery of her baby, and infant demise.

Design outcomes

Primary

MeasureTime frame
Breast milk production 14 days Volume in mL of breastmilk—

Secondary

MeasureTime frame
Adverse effect of domperidone 14 days Patient report of symptoms,Prolactin level 7 days blood level in microgram/L—

Countries

Thailand

Contacts

Public ContactMeera Khorana

College of Medicine, Rangsit University

meerambbs@yahoo.com0818162718

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026